<DOC>
	<DOCNO>NCT01887015</DOCNO>
	<brief_summary>To evaluate whether early application nasal high flow oxygen therapy extubation reduce incidence postoperative hypoxemia ( define PaO2/FiO2 ratio &lt; 300 ) abdominal surgery patient intermediate high risk postoperative pulmonary complication .</brief_summary>
	<brief_title>Optiflow® Prevent Post-Extubation Hypoxemia afteR Abdominal Surgery ( OPERA Trial )</brief_title>
	<detailed_description>Postoperative hypoxemia complicate 30 50 % patient abdominal surgery . Loss function alveolar unit development atelectasis abdominal surgery recognize underlying mechanism responsible postoperative hypoxemia . Supplemental Oxygen administration therefore widely recommended extubation postoperative period , especially patient high risk postoperative respiratory complication . Although oxygen therapy effective preventing vast majority severe postoperative hypoxemia extubation surgical patient , respiratory failure may occur , thus require endotracheal intubation mechanical ventilation therapeutic use non-invasive positive pressure ventilation ( NPPV ) . In patient postoperative hypoxemia ( defined patient PaO2/FiO2 ratio &lt; 300 ) , application NPPV find decrease incidence endotracheal intubation abdominal surgery . Nevertheless , use NPPV postoperative period responsible organizational constraint increase healthcare utilization . Nasal high flow cannula ( NHFC ) describe attractive well-tolerated method non-invasive oxygen delivery . Previous study show NHFC generates low level positive airway pressure , increase end-expiratory lung volume reduce airway resistance , thus contribute reduction work breathing . To date , however , clinical trial compare NHFC standard oxygen therapy prevention postoperative hypoxemia abdominal surgery patient intermediate high risk postoperative pulmonary complication . The primary objective study compare : 1- Standard oxygen therapy ; 2- Nasal high flow oxygen therapy extubation patient intermediate high risk postoperative pulmonary complication abdominal surgery . Our hypothesis , compare standard oxygen therapy , early application nasal high flow oxygen therapy reduce need postoperative NPPV postoperative hypoxemia ( define PaO2/FiO2 ratio &lt; 300 ) .</detailed_description>
	<mesh_term>Anoxia</mesh_term>
	<criteria>Planned unplanned surgical procedure Abdominal abdominal thoracic surgery Expected duration ≥2 hour ARISCAT score ≥26 point Age &lt; 18 year Body mass index &gt; 35 kg/m2 Sleep apnea syndrome Patient refusal Pregnancy and/or lactation</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Postoperative pulmonary complication</keyword>
	<keyword>Oxygen therapy</keyword>
	<keyword>Nasal high flow oxygen therapy</keyword>
	<keyword>Nasal high flow cannula</keyword>
</DOC>